AVEO Oncology
AVEO
#7560
Rank
ยฃ0.38 B
Marketcap
ยฃ11.20
Share price
0.00%
Change (1 day)
172.21%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -ยฃ22.91 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are ยฃ94.31 Million. In 2021 the company made an earning of -ยฃ39.83 Million a decrease over its 2020 earnings that were of -ยฃ26.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -ยฃ22.91 Million-42.48%
2021 -ยฃ39.83 Million49.9%
2020 -ยฃ26.57 Million-479.04%
2019 ยฃ7 M-276.17%
2018 -ยฃ3.98 Million-91.79%
2017 -ยฃ48.48 Million142.38%
2016 -ยฃ20.01 Million78.51%
2015 -ยฃ11.21 Million-71.55%
2014 -ยฃ39.38 Million-50.72%
2013 -ยฃ79.92 Million-4.88%
2012 -ยฃ84.02 Million-426.29%
2011 ยฃ25.74 M-159.85%
2010 -ยฃ43.03 Million35.33%
2009 -ยฃ31.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
ยฃ23.24 B-107,283.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.78 B-31,392.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.21 B-5,689.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ3.85 B-17,858.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.16 B-33,148.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-ยฃ1.69 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA